RegeneRx has join hands with the U.S. Army Medical Research Institute of Chemical Defense and Gabriel Sosne, MD, associate professor of ophthalmology at Wayne State University, to evaluate the ability of its eye drop formulation of Tß4 for preventing or reducing damage to the eye caused by exposure to chemical agents.
Scientist shall present study results of Epidemic Kerato-Conjunctivitis (EKC) drug at Diseases and Drug Discovery conference
The studies on nanoviricide drug candidates against Epidemic Kerato-Conjunctivitis (EKC) were conducted at the Feinstein Institute for Medical Research of the NSLIJ. Dr. Boniuk will be speaking at the GTC-Bio Conference on Ocular Diseases and Drug Discovery on April 21 in Philadelphia, PA.
Blindness due to macular degeneration (AMD) could be cured by stem cell therapy Stem cell therapy may cure blindness
The world’s first stem cell therapy to cure the most common cause of blindness has been developed by British researchers.
An Indian Sugar Factory in Ethiopia signed a memorandum of understanding with the Addis Ababa City Health Bureau to establish an Ophthalmology center worth a million dollars 12,000 msq in the premises of Zewditu Memorial Hospital. The eye care center will be called OIA India Eye Care Center.
Drug developer Pfizer Inc. announced on Tuesday that they have tide up with a five year deal with Bausch & Lomb- to co-promote prescription eye-care drugs in the United States of America.
On May 29, in the annual meeting of Global Health council, Washington, the Aravind eye care system based in Tamil Nadu in Southern India is going to get an award of $ 1 million. It is the worlds largest prize for international health. This eye care system has a large surgery network in India that has prevented blindness in millions of people.